NEHAL PATEL: Open Payments
NPI 1265012231 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,465 in 68 payments from 23 companies in 2025. Trend: 2023 $521 · 2024 $1,063 · 2025 $2,465
Food & beverage: $2,465
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $860 |
| Amgen Inc. | 11 | $265 |
| AstraZeneca Pharmaceuticals LP | 6 | $237 |
| Novartis Pharmaceuticals Corporation | 8 | $152 |
| SCPHARMACEUTICALS INC. | 1 | $115 |
| Esperion Therapeutics, Inc. | 5 | $99 |
| Kestra Medical Technology Services, Inc. | 4 | $97 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Boston Scientific Corporation | 3 | $71 |
Products named: Rapiblyk, REPATHA, LEQVIO, LOKELMA, FUROSCIX, NEXLETOL, Assure WCD, LifeVest.
Industry payments across FL — which companies pay providers there.
